Meeting Overview - The board meeting was held on August 25, 2025, in Dongying City, Shandong Province, with all 9 directors present and voting [1][2] - The meeting was chaired by Chairman Guo Tianming [1] Resolutions Passed - Approval of the establishment of a special account for raised funds and authorization for signing the fund supervision agreement [2] - Approval to increase the estimated amount for daily related party transactions by 35 million yuan [2][3] - Approval of the 2025 semi-annual report and its summary [4][5] - Approval of the revision of the "Fund Management Measures" [5] - Approval to convene the fourth extraordinary general meeting of shareholders in 2025 [5] Fund Management - The company plans to open a special account for raised funds in compliance with relevant laws and regulations, ensuring dedicated management of the funds [2] - The board authorized the legal representative or authorized person to handle the establishment of the special account and related agreements [2] Related Party Transactions - The increase in the estimated amount for daily related party transactions was deemed necessary for the company's operational needs, with fair pricing and no harm to the interests of the company or minority shareholders [3] Financial Reporting - The audit committee confirmed that the semi-annual report and its summary contained no false records or misleading statements [4]

Fundraising Overview - The company raised a total of RMB 1,999,175,984.31 through the issuance of 35,997,120 shares at a price of RMB 55.56 per share, with net proceeds after expenses amounting to RMB 1,991,750,984.31 [1][2] - As of June 30, 2025, the balance in the fundraising account was RMB 84,649,625.21 after various expenditures and investments [1][2] Fund Utilization - The company has utilized RMB 337,207,927.30 for project expenditures, with RMB 181,008,939.70 spent in the first half of 2025 [1][2] - A significant portion of the funds, RMB 1,790,000,000.00, was allocated to financial products, with RMB 1,050,000,000.00 recovered from these investments [1][2] Fund Management - The company has established a management system for fundraising in compliance with relevant laws and regulations, ensuring proper storage, utilization, and supervision of the funds [1][2] - Multiple banks have been engaged for the storage of funds, with specific agreements in place to ensure compliance with regulatory requirements [1][2] Investment Projects - The company is focused on the construction of a production line for string and energy storage inverters, with a planned capacity of 25.5 GW, expected to be operational by the end of 2025 [3] - As of June 30, 2025, the cumulative investment progress for this project was 46.24%, impacted by market conditions and industry dynamics [3] Cash Management - The company has approved the temporary use of idle fundraising for cash management, with a limit of RMB 800,000,000.00 for safe and liquid financial products [2][3] - Various structured deposits have been utilized for cash management, with specific amounts and durations detailed in the report [2][3]

证券代码：688072 证券简称：拓荆科技 公告编号：2025-039 拓荆科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规 则》和《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等有关规定，拓荆科技股份有限公司（以下简称"公司"）董事会对公司 2025 年半年度（以下简称"报告期"）募集资金存放与实际使用情况专项报告如下： 一、募集资金基本情况 （一）实际募集资金的金额及资金到账情况 根据中国证券监督管理委员会于 2022 年 3 月 1 日出具的《关于同意拓荆科 技股份有限公司首次公开发行股票注册的批复》（证监许可[2022]424 号），公 司首次向社会公众公开发行人民币普通股（A 股）股票 31,619,800 股，每股面 值为人民币 1 元。本次发行价格为每股人民币 71.88 元，募集资金总额为人民 币 227,283.12 万元，扣除发行费用人民币 14,523.40 万元后，募集资金净额为人 民币 212, ...

Core Points - The company raised a total of RMB 1,200,000,000 by issuing 48,000,000 shares, with a net amount of RMB 1,187,009,433.95 after deducting issuance costs [1][2] - As of June 30, 2025, the company has utilized RMB 67,791.10 million of the raised funds, with RMB 61,264.34 million used to replace self-funded investments in projects [2][3] - The remaining balance of the raised funds is RMB 50,952.28 million [1][3] Fund Management - The company has established a dedicated account for the management of raised funds, adhering to relevant regulations and guidelines [1][2] - A tripartite agreement for fund storage was signed with China Bank and CITIC Securities, ensuring proper oversight of the funds [1][2] - As of June 30, 2025, the total balance in the dedicated accounts is RMB 509,522,777.79 [2][3] Fund Usage - The company has not used any idle raised funds to temporarily supplement working capital [3][4] - A resolution was passed to use up to RMB 55,000 million of idle funds for cash management, focusing on safe and liquid investment products [3][4] - The company has not utilized any excess raised funds for permanent working capital or loan repayment [4][5] Project Investment - The company has adjusted the funding sources for its projects, using raised funds instead of self-owned funds for investments in subsidiaries [5][6] - There have been no changes to the planned use of raised funds for investment projects during the reporting period [6][7] - The company has completed the replacement of self-funded investments in projects with raised funds as of June 30, 2025 [3][6]

Summary of Key Points Core Viewpoint The report outlines the management and usage of funds raised through a private placement of shares by the company, detailing the total amount raised, its allocation, and the regulatory compliance measures in place to ensure proper fund management. Fundraising Overview - The company raised a total of RMB 1,814,116,286.85 through the issuance of 396,334,048 shares at a price of RMB 4.61 per share, with the funds received on January 16, 2023 [1]. - The funds were verified by Tianzhi International Accounting Firm on the same date [1]. Fund Usage as of June 30, 2025 - Total funds used in 2023: RMB 658,743,205.38 - Total funds used in 2024: RMB 108,815,397.10 - Total funds used in 2025: RMB 67,405,248.47 - Other issuance costs: RMB 3,999,786.90 - Temporary liquidity support: RMB 890,000,000.00 - Interest income from deposits: RMB 4,712,834.96 [2]. Fund Management Practices - The company has established a dedicated fund management system in compliance with relevant laws and regulations, including a special account storage system [2][3]. - A tripartite supervision agreement was signed with several banks to ensure proper management of the raised funds [2][3]. Fund Balance and Account Management - As of June 30, 2025, the total balance in the fund storage accounts was RMB 93,713,658.58, with specific balances in various banks [5]. - The company has completed the necessary procedures to close the special fund accounts, with a balance of zero [5][14]. Temporary Use of Idle Funds - The company has utilized idle funds to temporarily supplement working capital, with a total of RMB 105,000,000.00 used in 2023 and fully returned by January 22, 2024 [6][10]. - An additional RMB 96,000,000.00 was used for working capital, with a portion returned by June 9, 2025 [11] . Cash Management Initiatives - The company approved the use of up to RMB 10.5 billion of idle funds for cash management, investing in low-risk, liquid financial products [12][10]. - Agreements for cash management were signed with multiple banks to facilitate this process [12][10]. Project Implementation Status - The company is actively working on its fundraising projects, although the pace of fund usage has been slower than planned, with ongoing efforts to expedite project progress [8][9].

深圳清溢光电股份有限公司 二〇二五年八月 目 录 第一章 总则 第一条 为规范深圳清溢光电股份有限公司（以下简称"公司"）募集资金 的管理和使用，提高募集资金使用的效率和效果，防范资金使用风险，确保资金 使用安全，切实保护投资者利益，根据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司募集资金监管规则》《上海证券交易所科创板股票上市 规则》（以下简称"《上市规则》"）、《上海证券交易所科创板上市公司自律 监管指引第1号——规范运作》《深圳清溢光电股份有限公司章程》（以下简称 "《公司章程》"）和其他有关法律、法规和规范性文件的规定，结合公司实际 情况，制定本《深圳清溢光电股份有限公司募集资金管理制度》（以下简称"《管 理制度》"）。 第二条 本《管理制度》所称募集资金是指公司通过向不特定对象发行证券 （包括首次公开发行股票、配股、增发、发行可转换公司债券、发行分离交易的 可转换公司债券等）以及向特定对象发行证券募集的资金，但不包括公司实施股 权激励计划募集的资金。 公司应当真实、准确、完整地披露募集资金的实际使用情况。 公司董事会应持续关注募集资金存放、管理和使用情况，有效防范投资风险， 提高募集 ...

浙江海正药业股份有限公司募集资金管理办法 浙江海正药业股份有限公司 募集资金管理办法 第一章 总则 第一条 为了规范本公司募集资金的使用与管理，提高募集资金使用效益，保护 投资者的合法权益，根据《公司法》 《证券法》 《首次公开发行股票注册管理办法》 《上 市公司证券发行注册管理办法》 《上市公司募集资金监管规则》 《上海证券交易所股票 上市规则》及《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关 法律法规，制定本办法。 第二条 本办法适用于公司通过发行股票或者其他具有股权性质的证券，向投资 者募集并用于特定用途的资金监管，但不包括上市公司为实施股权激励计划募集的资 金监管。 本办法所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 公司募集资金应当专款专用。募集资金只能用于公司对外披露的募集资 金投资项目（以下简称"募投项目"），公司负责制定详细的募集资金使用计划。募集 资金的管理应遵循规范、安全、高效、透明的原则。 《监管规则适用指引——上市类第 1 号》对上市公司发行股份、可转换公司债券 购买资产并募集配套资金用途另有规定的，从其规定。 第四条 募投项目通过公司的子公 ...

Group 1 - The company has decided to postpone the implementation of the "annual production of 8,000 tons of organic pigment production project" due to the current market conditions where supply exceeds demand, and the industry capacity growth is expected to outpace demand growth [1][2] - The company aims to enhance its independent research and development capabilities for key technologies of its leading products, providing technical support for the upgrade of high-performance organic pigment products and new growth points [1][2] - The company has indicated that the demand for new varieties of organic pigments from downstream customers has slowed down, and it will focus its R&D efforts based on customer needs [1][2] Group 2 - The company has conducted six inquiries into the special account for raised funds, ensuring compliance with internal regulations and effective execution of relevant rules [1] - The company has not reported any issues requiring attention, and there have been no instances of unfulfilled commitments or significant changes in financial status, management, or core technology [2] - The company has not conducted any training sessions or reported any matters requiring regulatory measures [2]

项目总投资额 拟使用募集资金投 公司首次公开发行股票已经中国证券监督管理委员会"证监许可〔2023〕361 号"文同意注册，公司公开发行人民币普通股（A 股）股票 19,000,000 股，发行 价格为 58.32 元/股，募集资金总额为人民币 1,108,080,000.00 元，扣除发行费用 （ 不 含 增 值 税 ） 人 民 币 103,717,534.12 元 后 ， 募 集 资 金 净 额 为 人 民 币 金到账情况进行了审验，并于 2023 年 4 月 13 日出具了[2023]3138 号《验资报告》。 公司已对募集资金采取专户存储管理，设立了募集资金专项账户并与银行签 订了《募集资金三方监管协议》。 二、募集资金投资项目的具体情况 序号 项目名称 东方证券股份有限公司 关于深圳光大同创新材料股份有限公司部分募投项目结项 并将节余募集资金永久补充流动资金的核查意见 东方证券股份有限公司（以下简称"东方证券"、 "保荐机构"）作为深圳光大 同创新材料股份有限公司（以下简称"光大同创"、"公司"）首次公开发行股票并 在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司 募集资金监管 ...

Summary of Key Points Core Viewpoint - The company has completed certain fundraising projects and plans to permanently supplement its working capital with the remaining funds from these projects, which aligns with its operational needs and regulatory requirements [1][9]. Group 1: Fundraising Overview - The company was approved to publicly issue 36.67 million shares at a price of RMB 43.67 per share, raising a total of RMB 1,601,378,900.00, with a net amount of RMB 1,442,913,368.76 after deducting related fees [1][2]. - The funds are managed in a dedicated account under the supervision of the sponsor and the bank, ensuring compliance with regulations [1][5]. Group 2: Investment Project Details - The total investment for the fundraising projects is RMB 122,584.90 million, with RMB 75,000.00 million allocated from the raised funds for various projects, including planning and construction, R&D, and working capital [3][4]. - Adjustments were made to the internal investment structure of the "Planning and Construction Project" while keeping the total investment unchanged [4][5]. Group 3: Project Completion and Fund Usage - The "Planning and Construction Project" has reached a usable state, with a total of RMB 32,900.00 million committed, and an expected surplus of RMB 970.32 million, which is 2.95% of the total investment [5][6]. - The surplus funds will be permanently transferred to the company's general bank account to support daily operations, while maintaining the dedicated account until all pending payments are settled [6][7]. Group 4: Approval and Compliance - The board of directors approved the project completions and the use of surplus funds on August 22, 2025, confirming that the decisions align with the company's business needs and legal regulations [7][8]. - The sponsor has verified that the project completions and fund reallocations comply with relevant regulations and do not harm the interests of the company or its shareholders [8][9].